Investor News & Updates

two people talking in front of bayer logo

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

1 - 10of 478 News
1 - 10of 478 News
June 25, 2026
Monsanto wins landmark Roundup™ case at U.S. Supreme Court
READ MORE
June 25, 2026
Immediate statement: US Supreme Court rules in favor of Monsanto in the Durnell case
READ MORE
June 17, 2026
Federal judge remands Monsanto class settlement case back to Missouri State Court
READ MORE
June 17, 2026
Not intended for UK Media
Bayer completes acquisition of Perfuse Therapeutics
READ MORE
June 15, 2026
Bayer’s low-dose MRI contrast agent approved in U.S.
READ MORE
June 10, 2026
European Medicines Agency confirms Bayer’s FXIa inhibitor marketing authorization application for assessment in secondary prevention of ischemic stroke
READ MORE
June 09, 2026
Jana Marlen Ackermann to be new Head of Investor Relations at Bayer
READ MORE
May 19, 2026
Not intended for U.S. and UK Media
New drug applications for Bayer’s FXIa inhibitor accepted by U.S. Food and Drug Administration under Priority Review and by Japan’s Ministry of Health, Labour and Welfare
READ MORE
May 12, 2026
First quarter of 2026:
Bayer reports solid start to the year and confirms currency-adjusted Group guidance for 2026
READ MORE
May 06, 2026
Not intended for UK Media
Bayer to acquire Perfuse Therapeutics to complement ophthalmology pipeline
READ MORE
1 - 10of 478 News
1 - 10of 478 News
Inform Yourself on Special Topics
Control Weeds Not Farming

Control Weeds, Not Farming

LEARN MORE
Farmers discussing their weed management

Everything You Need to Know About Glyphosate

LEARN MORE
some-bayer-group-headquarters

Managing Glyphosate Litigation

learn more
woman harvesting carrots

Managing and Mitigating PCB Litigation Risk

learn more